The Generic Drugs Market report by Precision Business Insights provides a comprehensive research approach combining primary and secondary research to ensure the highest possible accuracy in estimates and forecasts of the market size, share, growth, trends, key segments, competitive landscape, and ma ...

Japan Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033 The Japan generic drug market size reached USD 12.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 22.5 Billion by 2033, exhibiting a growth rate (CAGR) of 6.55% during ...

The Middle East and Africa generic drugs market was valued at USD 33.00 Billion in 2024, driven by increasing healthcare needs and strategic partnerships in the region. The market is expected to grow at a CAGR of 7.42% during the forecast period of 2025-2034, with the values likely to rise from USD ...

The Latin America generic drugs market was valued at USD 36.10 Billion in 2024, driven by increasing government initiatives to stimulate production and improve access to generic drugs in the region. The market is expected to grow at a CAGR of 6.33% during the forecast period of 2025-2034, with the v ...

The North America generic drugs market was valued at USD 177.20 Billion in 2024 driven by the rising demand for cost-effective medications and presence of a favorable regulatory environment. It is expected to grow at a CAGR of 6.80% during the forecast period of 2025-2034, with the values likely to ...

The Asia Pacific generic drugs market was valued at USD 48.70 Billion in 2024 driven by the increased government initiatives to ensure access to quality generic medicines at affordable prices across the region. It is expected to grow at a CAGR of 7.20% during the forecast period of 2025-2034, with t ...

Generic Pharmaceutical Manufacturing in the US The Generic Pharmaceutical Manufacturing industry is a globalized industry that manufactures drugs originally protected by patents. Revenue growth depends on patent expirations, FDA approvals of new drug applications and competition from foreign compani ...

PPI Euromonitor International's Industrial reports provide a 360 degree view of an industry. The Industrial market report offers a comprehensive guide to the size and shape of the Pharmaceuticals: ISIC 2423 market at a national level. It provides the latest retail sales data, allowing you to identif ...

According to our (Global Info Research) latest study, the global Myotonic Dystrophy Drug market size was valued at US$ 49.2 million in 2024 and is forecast to a readjusted size of USD 76.9 million by 2031 with a CAGR of 6.6% during review period. Myotonic dystrophy is a type of muscular dystrophy, a ...

According to our (Global Info Research) latest study, the global Superdisintegrants market size was valued at US$ 289 million in 2024 and is forecast to a readjusted size of USD 413 million by 2031 with a CAGR of 5.3% during review period. Superdisintegrants are substances routinely included in the ...

According to our (Global Info Research) latest study, the global Sphingosine 1-Phosphate Receptor 1 market size was valued at US$ 4092 million in 2024 and is forecast to a readjusted size of USD 7063 million by 2031 with a CAGR of 8.2% during review period. Sphingosine-1-phosphate receptor 1 (S1P re ...

According to our (Global Info Research) latest study, the global Medical Hemostatic Agents market size was valued at US$ 3998 million in 2024 and is forecast to a readjusted size of USD 5706 million by 2031 with a CAGR of 5.3% during review period. Mechanical agents (also called passive substances) ...

Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325412 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save ...

The global generic drugs market is projected to grow from USD 437.90 billion in 2024 to USD 1,148.55 billion by 2035, reflecting a strong CAGR of 9.36%. Generic drugs match brand-name drugs in active ingredient composition, effectiveness, and quality, but are usually sold at significantly lower pric ...

Global antiviral drugs market is estimated to be valued at USD 67.04 Bn in 2025 and is expected to exhibit a CAGR of 5.3% during the forecast period (2025-2032). The global antiviral drugs market has been witnessing steady growth over the past few years. Antiviral drugs, also known as antiviral agen ...

This study covers the world outlook for specialty injectable generics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country i ...

This study covers the world outlook for pure generic drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the re ...

This study covers the world outlook for specialty generics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the re ...

This study covers the world outlook for cold-chain generic drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of ...

This study covers the world outlook for generic drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, ...

This study covers the world outlook for generic biosimilars across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the r ...

This study covers the world outlook for branded generics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the regi ...

This study covers the world outlook for generic biosimilar large molecule injectables across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent sha ...

This study covers the world outlook for generic antiviral drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of t ...

This study covers the world outlook for generics in antivirals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of th ...